Elizabeth Donahue | Senior Director, Project Management
Thermo Fisher Scientific

Elizabeth Donahue, Senior Director, Project Management, Thermo Fisher Scientific

Elizabeth Donahue is a Senior Director of Project Management in the Peri- and Post-Approval Studies and Real-World Evidence team, PPD, part of Thermo Fisher Scientific. She brings over 18 years of CRO experience to her position. As an operational subject matter expert, Elizabeth is instrumental in the strategic delivery of trials with varying study design, including Phase III clinical trials, observational studies, registries, chart reviews, and long-term follow-up studies. Her therapeutic experience focuses on rare diseases, pediatric studies, and cell and gene therapies, which encompasses multiple indications in endocrinology, hematology, neurology, and more. Elizabeth is also a member of PPD’s Rare Disease and Pediatrics Center of Excellence, a group dedicated to delivering expertise and supporting clinical study teams across a variety of rare indications and those affecting children.

Appearances:



Day 1- World Orphan Drug Congress USA 2025 @ 14:00

Roundtable 3: Gene therapy for rare diseases: Clinical trial experiences and lessons learned

This roundtable discussion will look to discuss:

  • Challenges in designing gene therapy clinical trials
  • Lessoned learned around long term follow up, need for ongoing monitoring
  • Incorporating feedback from patients and families into trial design
  • Key considerations for gaining approval from regulatory bodies

Sponsored by Thermo Fisher Scientific.

last published: 14/Feb/25 16:25 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com